BrainStorm Cell Therapeutics
BCLI
#9868
Rank
A$9.95 M
Marketcap
$1.87
Share price
7.08%
Change (1 day)
577.15%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2024 (TTM): -A$18.98 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$37.56 Million, an increase over its 2021 earnings that were of -A$37.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$18.98 Million
2022 -A$37.56 Million-0.74%
2021 -A$37.84 Million-23.12%
2020 -A$49.22 Million36.8%
2019 -A$35.98 Million66.71%
2018 -A$21.58 Million181.66%
2017 -A$7.67 Million-0.6%
2016 -A$7.71 Million-41.31%
2015 -A$13.14 Million-8.22%
2014 -A$14.31 Million89.74%
2013 -A$7.55 Million42.27%
2012 -A$5.31 Million-12.45%
2011 -A$6.06 Million63.04%
2010 -A$3.72 Million35.52%
2009 -A$2.74 Million-48.99%
2008 -A$5.38 Million-44.39%
2007 -A$9.66 Million
2005 -A$5.01 Million-91.44%
2004 -A$58.45 Million94007.62%
2003 -A$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$2.37 B-12,406.95%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.85 Billion 4,263.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.23 Billion 6,226.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.03 B-10,613.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.17 Billion 758.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.4 Billion 1,944.40%๐Ÿ‡บ๐Ÿ‡ธ USA